Study to Evaluate Correlation of Blood Sugar Level and Glycosylated Haemoglobin at the Time of Admission with Severity of Acute Coronary Syndrome in Diabetic Patients


Jitendra Kodilkar
Manish Kolge
Neelima Chafekar
Mrunal Patil


Aim: To study the clinical profile of diabetic patients who present with Acute Coronary Syndrome (ACS) for the first time, to correlate the Blood Sugar Level (BSL) and Glycosylated hemoglobin (HbA1C) at the time of admission and the severity of acute coronary syndrome; and to assess the correlation between tight glycemic control of diabetics based on HbA1C estimation and presence of end organ damage in diabetics. Materials and Methods: The study was undertaken at our medical college in the medicine department. 64 adult patients who are known diabetics or detected for the first time presenting in outpatient department or emergency department as acute coronary syndrome were studied. Study period was 2 years from January 2011 to December 2012. Results: The study showed a definite male preponderance, with 56.23% males as compared to 43.73% females. Atypical presentations of acute coronary syndrome were more common as compared to typical chest pain (34.37%). Chest pain commonly is prevalent in younger age group. 95.30% of the patient had some or other associated risk factors like hypertension (59.37%), smoking (26.56%), obesity (15.62%) or dyslipidemia (65.62%). ST elevation MI was the commonest presentation (73.40%) and involvement of anterior wall was common (36.20%). On admission BSL (Blood Sugar Level) was not found to have a definite prognostic value in predicting outcome in diabetic patients with acute coronary syndrome. Impaired glycosylated haemoglobin was found to be an independent risk factor and had a definite prognostic value in predicting outcome. Diabetic patient with acute coronary syndrome had LV dysfunction, cardiac rhythm abnormalities, cardiogenic shock and are likely to be readmitted, thus having worst morbidity as well as mortality. Conclusion: The primary aim of this study was to study correlation of blood sugar level and glycosylated haemoglobin at the time of admission with severity of acute coronary syndrome and to study clinical profile of diabetic patients with due consideration to complications which are related to diabetes.


How to Cite
Kodilkar, J., Kolge, M., Chafekar, N., & Patil, M. (2018). Study to Evaluate Correlation of Blood Sugar Level and Glycosylated Haemoglobin at the Time of Admission with Severity of Acute Coronary Syndrome in Diabetic Patients. MVP Journal of Medical Sciences, 39–48.


  1. Ramchandran A. Epidemiology of type 2 diabetes and its complication in India, moses manual on diabetes mellitus, editors Das S and mosses CRA. New Delhi: IJCP Group of publications; 2007. p. 36–45.
  2. King H. Aubert RE, Herman WH. Global burden of diabetes 1995-2025.-Prevalence numerical estimate and projections. Diabetic care. 1998; 21:1414–31.
  3. Goyal A, Yusuf S. The burden of cardiovascular disease in the Indian subcontinent. Indian J Med Res. 2006; 124:235– 44. PMid:17085827
  4. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-Control Study. Lancet. 2004; 364:937–52.
  5. Ajay VS, Gupta R, Panniyammakkal J, et al. National cardiovascular disease database, delhi ministry of health and family welfare. Government of India. Geneva: World Health Organization; 2002
  6. Waller BF, Palumbo PJ, Lie JT, Roberts WC. Status of coronary artery disease at necropsy in diabetes mellitus after age 30 year: Analysis of 229 diabetic patients with and without evidence of coronary heart disease and comparison to 183 control subjects. Am J Med. 1980; 69:498–506
  7. Fuster V, Moreno PR, Fayad ZA, et al. Atherothrombosis and high-risk plaque: Part 1: evolving concept. J Am Cardiol. 2005; 46:937–54. PMid:16168274
  8. Malmberg K, Rydén L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt P, MacLeod K, Laakso M, Torp-Pedersen C, Waldenström. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005 Apr; 26(7):650–61. PMid:15728645
  9. Katayama T, Nakashima H, Takagi C, Honda Y, Suzuki S, Iwasaki Y, Yano K. Clinical outcomes and left ventricular function in diabetic patients with acute myocardial infarction treated by primary coronary angioplasty. Int Heart J. 2005 Jul; 46(4):607–18. PMid:16157952
  10. Mayer DD, Rosenfeld A. Symptom interpretation in women with diabetes and myocardial infarction. A qualitative study. The Diabetes Educator 2006 Nov-Dec; 32(6):6 918–24.
  11. Andersson DK, Svardsudd K. Long-term glycemic control relates to mortality in type II diabetes. Diabetes Care. 1995; 18:1534–43.
  12. 12. Klein R, Klein BE, Moss SE. The Wisconsin epidemiologic study of diabetic retinopathy. XVI. The relationship of C-peptide to the incidence and progression of diabetic retinopathy. Diabetes. 1995 Jul; 44(7):796–801. PMid:7789648
  13. Barrett-Connor E, Wingard DL. Sex differential in ischemic heart disease mortality in diabetics: A prospective populationbased study. Am J Epidemiol. 1983; 118:489–96. PMid:6637976
  14. Wei M, Gaskill SP, Haffner SM, et al. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care. 1998; 21:1167– 72. PMid:9653614
  15. Singer DE, Nathan DM, Anderson KM, et al. Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham heart study. Diabetes 1992; 41:202–8. PMid:1733810
  16. Hsu LF, Mak KH, Lau KW, Sim LL, Chan C, Koh TH, Chuah SC, Kam R, Ding ZP, Teo WS, Lim YL. Clinical outcomes of patients with diabetes mellitus and acute myocardial infarction treated with primary angioplasty or fibrinolysis. Heart. 2002 Sep; 88(3):260–5. heart.88.3.260 PMid:12181218 PMCid:PMC1767339
  17. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B. Intensive diabetes treatment and cardiovascular disease in patients with Type 1 diabetes. N Engl J Med, 2005; 353:2643–53. PMid:16371630 PMCid:PMC2637991

Most read articles by the same author(s)

1 2 3 > >>